17β-HSD11, also known as HSD17B11 (Hydroxysteroid 17-beta dehydrogenase 11), is an intriguing member of the 17β-hydroxysteroid dehydrogenases (17β-HSDs) family. This family is renowned for its essential roles in the meticulous balance of activation and inactivation processes of steroid hormones. While 17β-HSD11 itself is efficiently regulated by peroxisome proliferator-activated receptor-α (PPARα) predominantly in the intestine and the liver, other members of this family showcase an array of biological functions. For instance, HSD17B1 stands out as a pivotal enzyme in the estrogen metabolic pathway, being responsible for the activation of estrogens from their weaker precursors by catalyzing the biosynthesis' final step. This transformative process is indispensable for maintaining proper estrogenic levels vital for various physiological operations.
Diving deeper into the family, HSD17B12 is another significant member that wears multiple hats in cellular pathways. Not only does it play a role in the prostaglandin synthesis pathway, influencing ovarian function and fertility regulation, but it also carves a niche in the fatty acid biosynthesis pathway. Its involvement in the latter has been linked to predicting outcomes in colorectal cancer, underscoring the importance of this enzyme in disease contexts. As we shift our focus back to 17β-HSD11, the burgeoning interest in this protein suggests that 17β-HSD11 Activators would be compounds tailored to heighten the activity or expression of 17β-HSD11. These activators might either foster a direct interaction with the protein or modulate the intertwined signaling pathways it's associated with, amplifying the innate roles of 17β-HSD11.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
Fenofibrate is a well-known PPARα agonist that may enhance PPARα activity, potentially leading to increased expression of 17β-HSD11. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
Clofibrate is a PPARα agonist that may also enhance PPARα activity, potentially inducing 17β-HSD11 expression. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $65.00 $262.00 | 2 | |
Gemfibrozil is a fibric acid derivative and a PPARα agonist that may enhance PPARα activity, potentially leading to increased expression of 17β-HSD11. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $30.00 $45.00 $120.00 $200.00 | 5 | |
Bezafibrate is a pan-PPAR agonist, with activity on PPARα, potentially inducing 17β-HSD11 expression through PPARα activation. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $133.00 | 7 | |
WY-14643 is a potent PPARα agonist that may enhance PPARα activity, potentially leading to increased expression of 17β-HSD11. | ||||||
GW 7647 | 265129-71-3 | sc-203068A sc-203068 sc-203068B sc-203068C | 1 mg 5 mg 10 mg 25 mg | $48.00 $167.00 $262.00 $648.00 | 6 | |
GW7647 is a highly potent and selective PPARα agonist that may enhance PPARα activity, potentially inducing 17β-HSD11 expression. | ||||||
Ciprofibrate | 52214-84-3 | sc-204689 sc-204689A | 25 mg 100 mg | $57.00 $169.00 | ||
Ciprofibrate is a potent PPARα agonist that may enhance PPARα activity, potentially leading to increased expression of 17β-HSD11. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Although primarily a PPARγ agonist, Rosiglitazone may also have some activity on PPARα, potentially inducing 17β-HSD11 expression. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Similar to Rosiglitazone, Pioglitazone primarily targets PPARγ but may also affect PPARα activity, potentially inducing 17β-HSD11 expression. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $36.00 $102.00 $569.00 $1173.00 | 10 | |
Oleic Acid has been reported to activate PPARα, potentially leading to increased expression of 17β-HSD11. | ||||||